InsiderTrades.com logo
The latest trend in real estate
From Pacaso   |   Ad
These vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, they’re being transformed into fully utilized assets. And there’s one company that’s leading the charge – already welcoming over 1,500 happy homeowners into their co-ownership family, earning $100M in gross profits along the way. Now, for the first time, this innovative company is opening its doors to public investors. Want to learn more about co-ownership and its potential? Check them out – but be aware: their share price is set to change December 5, so you don’t have long to maximize your stake.
Don’t miss your chance to maximize your stake in this co-ownership revolution.

TGTX Insider Trading

Insider Ownership Percentage: 10.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,645,995.97

TG Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at TG Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TG Therapeutics Share Price & Price History

Current Price: $35.00
Price Change: ▲ Price Increase of +0.74 (2.16%)
As of 11/27/2024 07:16 PM ET

This chart shows the closing price history over time for TGTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The latest trend in real estate
From Pacaso   |   Ad
These vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, they’re being transformed into fully utilized assets. And there’s one company that’s leading the charge – already welcoming over 1,500 happy homeowners into their co-ownership family, earning $100M in gross profits along the way. Now, for the first time, this innovative company is opening its doors to public investors. Want to learn more about co-ownership and its potential? Check them out – but be aware: their share price is set to change December 5, so you don’t have long to maximize your stake.
Don’t miss your chance to maximize your stake in this co-ownership revolution.

TG Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/11/2024Sagar LonialDirectorSell5,000$30.44$152,200.00100,195View SEC Filing Icon  
3/12/2024Laurence N. CharneyDirectorSell22,000$15.97$351,340.00215,229View SEC Filing Icon  
1/5/2024Laurence N. CharneyDirectorSell17,500$19.03$333,025.00237,229View SEC Filing Icon  
1/3/2024Sean A. PowerCFOSell47,867$16.91$809,430.97606,969View SEC Filing Icon  
8/11/2023Michael S. WeissCEOBuy100,000$10.13$1,013,000.0012,073,021View SEC Filing Icon  
6/23/2023Sagar LonialDirectorSell34,854$23.37$814,537.9893,878View SEC Filing Icon  
6/2/2023Sean A. PowerCFOSell73,647$26.70$1,966,374.90654,836View SEC Filing Icon  
1/6/2023Yann EchelardDirectorBuy9,000$10.64$95,760.00201,848View SEC Filing Icon  
1/4/2023Laurence N. CharneyDirectorSell30,000$11.10$333,000.00234,729View SEC Filing Icon  
1/4/2022Michael S. WeissCEOSell37,549$19.20$720,940.80View SEC Filing Icon  
1/4/2022Sean A. PowerCFOSell75,312$19.20$1,445,990.40View SEC Filing Icon  
See Full Table
The latest trend in real estate
From Pacaso   |   Ad
These vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, they’re being transformed into fully utilized assets. And there’s one company that’s leading the charge – already welcoming over 1,500 happy homeowners into their co-ownership family, earning $100M in gross profits along the way. Now, for the first time, this innovative company is opening its doors to public investors. Want to learn more about co-ownership and its potential? Check them out – but be aware: their share price is set to change December 5, so you don’t have long to maximize your stake.
Don’t miss your chance to maximize your stake in this co-ownership revolution.

SEC Filings (Institutional Ownership Changes) for TG Therapeutics (NASDAQ:TGTX)

58.58% of TG Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TGTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

TG Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/27/2024Franklin Resources Inc.128,985$2.95M0.0%+3.8%0.083%Search for SEC Filing on Google Icon
11/25/2024Synovus Financial Corp19,900$0.47M0.0%N/A0.013%Search for SEC Filing on Google Icon
11/18/2024Teachers Retirement System of The State of Kentucky44,450$1.04M0.0%N/A0.029%Search for SEC Filing on Google Icon
11/18/2024Neo Ivy Capital Management100,780$2.36M0.8%N/A0.065%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC3,205,228$74.98M0.0%0.0%2.059%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC347,057$8.12M0.0%+83.9%0.223%Search for SEC Filing on Google Icon
11/15/2024Castleark Management LLC168,810$3.95M0.2%N/A0.108%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP73,320$1.72M0.0%+12.7%0.047%Search for SEC Filing on Google Icon
11/15/2024State Street Corp9,094,158$212.71M0.0%+35.8%5.842%Search for SEC Filing on Google Icon
11/15/2024Parkman Healthcare Partners LLC126,471$2.96M0.4%-29.9%0.081%Search for SEC Filing on Google Icon
11/15/2024HighTower Advisors LLC12,526$0.29M0.0%+19.6%0.008%Search for SEC Filing on Google Icon
11/14/2024PFM Health Sciences LP233,410$5.46M0.3%N/A0.150%Search for SEC Filing on Google Icon
11/14/2024PDT Partners LLC60,669$1.42M0.1%N/A0.039%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC45,699$1.07M0.0%-12.6%0.029%Search for SEC Filing on Google Icon
11/14/2024Captrust Financial Advisors30,327$0.71M0.0%+21.1%0.019%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC293,927$6.88M0.0%-8.7%0.189%Search for SEC Filing on Google Icon
11/14/2024Public Sector Pension Investment Board283,000$6.62M0.0%N/A0.182%Search for SEC Filing on Google Icon
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank 31,147$0.73M0.0%+12.0%0.020%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets117,985$2.76M0.0%-17.3%0.076%Search for SEC Filing on Google Icon
11/13/2024Advantage Alpha Capital Partners LP22,379$0.52M0.1%-34.2%0.014%Search for SEC Filing on Google Icon
11/13/2024FMR LLC1,184,158$27.70M0.0%-2.6%0.761%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 79,191$1.85M0.0%-1.8%0.051%Search for SEC Filing on Google Icon
11/13/2024Harvest Fund Management Co. Ltd4,761$0.11M0.0%N/A0.003%Search for SEC Filing on Google Icon
11/12/2024Penserra Capital Management LLC98,144$2.30M0.0%+293.6%0.063%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC104,252$2.44M0.1%-29.2%0.067%Search for SEC Filing on Google Icon
11/12/2024Citigroup Inc.168,277$3.94M0.0%+125.7%0.109%Search for SEC Filing on Google Icon
11/12/2024Eagle Asset Management Inc.168,795$3.95M0.0%N/A0.109%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.1,184,609$27.71M0.0%+0.7%0.765%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC48,263$1.13M0.0%N/A0.031%Search for SEC Filing on Google Icon
11/8/2024Segall Bryant & Hamill LLC52,390$1.23M0.0%N/A0.034%Search for SEC Filing on Google Icon
11/8/2024Prospera Financial Services Inc35,713$0.84M0.0%-7.1%0.023%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC10,529$0.25M0.0%N/A0.007%Search for SEC Filing on Google Icon
11/7/2024Swiss National Bank286,600$6.70M0.0%-0.7%0.185%Search for SEC Filing on Google Icon
11/7/2024Thrivent Financial for Lutherans104,764$2.45M0.0%N/A0.068%Search for SEC Filing on Google Icon
11/6/2024Mutual of America Capital Management LLC20,064$0.47M0.0%N/A0.013%Search for SEC Filing on Google Icon
11/6/2024Empowered Funds LLC46,431$1.09M0.0%+3.1%0.030%Search for SEC Filing on Google Icon
11/6/2024KBC Group NV4,675$0.11M0.0%+30.5%0.003%Search for SEC Filing on Google Icon
11/6/2024Oppenheimer & Co. Inc.32,470$0.76M0.0%N/A0.021%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.32,679$0.76M0.0%+24.7%0.021%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP10,987$0.26M0.0%-55.1%0.007%Search for SEC Filing on Google Icon
11/5/2024Entropy Technologies LP31,200$0.73M0.1%N/A0.020%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC123,401$2.89M0.0%+33.7%0.080%Search for SEC Filing on Google Icon
11/4/2024State of New Jersey Common Pension Fund D82,752$1.94M0.0%-27.2%0.053%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.772,188$18.06M0.0%+1,549.4%0.500%Search for SEC Filing on Google Icon
10/30/2024Amalgamated Bank39,528$0.93M0.0%+712.0%0.026%Search for SEC Filing on Google Icon
10/25/2024Iridian Asset Management LLC CT47,532$1.11M0.2%+20.8%0.031%Search for SEC Filing on Google Icon
10/25/2024New York State Teachers Retirement System42,927$1M0.0%N/A0.028%Search for SEC Filing on Google Icon
10/24/2024State of Alaska Department of Revenue76,130$1.78M0.0%N/A0.049%Search for SEC Filing on Google Icon
10/23/2024Louisiana State Employees Retirement System64,500$1.51M0.0%N/A0.042%Search for SEC Filing on Google Icon
10/23/2024CWC Advisors LLC.16,150$0.38M0.4%N/A0.010%Search for SEC Filing on Google Icon
10/23/2024Values First Advisors Inc.2,496$58K0.0%N/A0.002%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.170,234$3.98M0.0%-65.2%0.110%Search for SEC Filing on Google Icon
10/23/2024Hennion & Walsh Asset Management Inc.98,629$2.31M0.1%-2.7%0.064%Search for SEC Filing on Google Icon
10/22/2024Private Advisor Group LLC14,407$0.34M0.0%+3.9%0.009%Search for SEC Filing on Google Icon
10/21/2024Everence Capital Management Inc.16,260$0.38M0.0%N/A0.011%Search for SEC Filing on Google Icon
10/21/2024Wealth Effects LLC14,500$0.34M0.1%-12.1%0.009%Search for SEC Filing on Google Icon
10/19/2024Allspring Global Investments Holdings LLC17,118$0.40M0.0%-6.5%0.011%Search for SEC Filing on Google Icon
10/18/2024Raymond James & Associates170,160$3.98M0.0%+35.9%0.110%Search for SEC Filing on Google Icon
10/18/2024Blue Trust Inc.1,516$35K0.0%+127.3%0.001%Search for SEC Filing on Google Icon
10/16/2024Avaii Wealth Management LLC28,984$0.68M0.3%-4.1%0.019%Search for SEC Filing on Google Icon
10/16/2024Vontobel Holding Ltd.9,500$0.22M0.0%N/A0.006%Search for SEC Filing on Google Icon
10/15/2024NBC Securities Inc.1,309$30K0.0%+58.9%0.001%Search for SEC Filing on Google Icon
10/11/2024Creative Planning55,832$1.31M0.0%+19.2%0.036%Search for SEC Filing on Google Icon
10/11/2024ORG Wealth Partners LLC2,252$53K0.0%N/A0.001%Search for SEC Filing on Google Icon
10/10/2024Valeo Financial Advisors LLC10,223$0.24M0.0%N/A0.007%Search for SEC Filing on Google Icon
10/8/2024Daymark Wealth Partners LLC40,811$0.96M0.0%+73.7%0.026%Search for SEC Filing on Google Icon
10/5/2024Handelsbanken Fonder AB49,900$1.17M0.0%+22.6%0.032%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC23,614$0.55M0.0%+181.9%0.015%Search for SEC Filing on Google Icon
9/16/2024Point72 Asia Singapore Pte. Ltd.10,166$0.18M0.0%-57.2%0.007%Search for SEC Filing on Google Icon
9/11/2024Newbridge Financial Services Group Inc.3,084$55K0.0%-15.8%0.002%Search for SEC Filing on Google Icon
8/22/2024Cetera Investment Advisers53,425$0.95M0.0%-15.3%0.035%Search for SEC Filing on Google Icon
8/19/2024Point72 Asset Management L.P.585,873$10.42M0.0%N/A0.379%Search for SEC Filing on Google Icon
8/16/2024Quarry LP6,003$0.11M0.0%+9.1%0.004%Search for SEC Filing on Google Icon
8/16/2024Creative Planning46,839$0.83M0.0%+34.7%0.030%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC147,218$2.62M0.1%+193.8%0.095%Search for SEC Filing on Google Icon
8/15/2024Lighthouse Investment Partners LLC111,092$1.98M0.1%N/A0.072%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company80,664$1.44M0.0%+3.7%0.052%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC1,457,908$25.94M0.0%-57.4%0.943%Search for SEC Filing on Google Icon
8/15/2024Dark Forest Capital Management LP41,252$0.73M0.1%N/A0.027%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC38,025$0.68M0.0%-14.3%0.025%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.10,166$0.18M0.0%-57.2%0.007%Search for SEC Filing on Google Icon
8/15/2024Point72 Europe London LLP160,769$2.86M0.2%N/A0.104%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC51,711$0.92M0.0%-15.6%0.033%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP2,051,762$36.50M0.0%N/A1.328%Search for SEC Filing on Google Icon
8/14/2024Magnetar Financial LLC36,753$0.65M0.0%-29.5%0.024%Search for SEC Filing on Google Icon
8/14/2024Hood River Capital Management LLC1,572,929$27.98M0.6%+6.7%1.018%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC18,575$0.33M0.0%-25.4%0.012%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC62,616$1.11M0.0%-27.0%0.041%Search for SEC Filing on Google Icon
8/13/2024Sei Investments Co.37,557$0.67M0.0%-3.3%0.024%Search for SEC Filing on Google Icon
8/13/2024Canada Pension Plan Investment Board1,500$27K0.0%-96.7%0.001%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd22,176$0.40M0.0%N/A0.014%Search for SEC Filing on Google Icon
8/12/2024E Fund Management Co. Ltd.20,465$0.36M0.0%-20.8%0.013%Search for SEC Filing on Google Icon
8/10/2024Sofinnova Investments Inc.1,861,277$33.11M1.7%-6.2%1.204%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC309,371$5.50M0.0%-63.2%0.200%Search for SEC Filing on Google Icon
8/8/2024J.W. Cole Advisors Inc.15,700$0.28M0.0%-18.9%0.010%Search for SEC Filing on Google Icon
8/8/2024State of New Jersey Common Pension Fund D113,683$2.02M0.0%N/A0.074%Search for SEC Filing on Google Icon
8/7/2024Headlands Technologies LLC6,980$0.12M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/7/2024Ashton Thomas Private Wealth LLC1,986$35K0.0%N/A0.001%Search for SEC Filing on Google Icon
8/6/2024Strategic Financial Concepts LLC29,776$0.53M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/6/2024Los Angeles Capital Management LLC92,277$1.64M0.0%+20.4%0.060%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
TG Therapeutics logo
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Umbralisib, an oral inhibitor of PI3K-delta inhibitor for the treatment of adult patients with relapsed or refractory marginal zone lymphoma and follicular lymphoma; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. was incorporated in 1993 and is based in Morrisville, North Carolina.
Read More on TG Therapeutics

Today's Range

Now: $35.00
Low: $33.67
High: $35.07

50 Day Range

MA: $26.19
Low: $21.31
High: $35.07

52 Week Range

Now: $35.00
Low: $12.32
High: $36.84

Volume

1,680,767 shs

Average Volume

3,686,240 shs

Market Capitalization

$5.45 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.19

Who are the company insiders with the largest holdings of TG Therapeutics?

TG Therapeutics' top insider investors include:
  1. Michael S Weiss (CEO)
  2. Sean A Power (CFO)
  3. Laurence N Charney (Director)
  4. Yann Echelard (Director)
  5. Sagar Lonial (Director)
Learn More about top insider investors at TG Therapeutics.

Who are the major institutional investors of TG Therapeutics?

TG Therapeutics' top institutional shareholders include:
  1. State Street Corp — 5.84%
  2. Geode Capital Management LLC — 2.06%
  3. Charles Schwab Investment Management Inc. — 0.77%
  4. FMR LLC — 0.76%
  5. Principal Financial Group Inc. — 0.50%
  6. Barclays PLC — 0.22%
Learn More about top institutional investors of TG Therapeutics stock.

Which institutional investors are selling TG Therapeutics stock?

In the previous quarter, TGTX stock was sold by these institutional investors:
  1. Assenagon Asset Management S.A.
  2. Walleye Capital LLC
  3. Parkman Healthcare Partners LLC
  4. Algert Global LLC
  5. FMR LLC
  6. State of New Jersey Common Pension Fund D
  7. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  8. BNP Paribas Financial Markets
In the previous year, company insiders that have sold TG Therapeutics company stock include:
  1. Michael S Weiss (CEO)
  2. Sean A Power (CFO)
  3. Laurence N Charney (Director)
Learn More investors selling TG Therapeutics stock.

Which institutional investors are buying TG Therapeutics stock?

In the last quarter, TGTX stock was bought by institutional investors including:
  1. State Street Corp
  2. Principal Financial Group Inc.
  3. Public Sector Pension Investment Board
  4. PFM Health Sciences LP
  5. Castleark Management LLC
  6. Eagle Asset Management Inc.
  7. Barclays PLC
  8. Thrivent Financial for Lutherans
Within the previous year, these company insiders have bought TG Therapeutics stock:
  1. Michael S Weiss (CEO)
  2. Sean A Power (CFO)
Learn More investors buying TG Therapeutics stock.
The latest trend in real estate
From Pacaso   |   Ad
These vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, they’re being transformed into fully utilized assets. And there’s one company that’s leading the charge – already welcoming over 1,500 happy homeowners into their co-ownership family, earning $100M in gross profits along the way. Now, for the first time, this innovative company is opening its doors to public investors. Want to learn more about co-ownership and its potential? Check them out – but be aware: their share price is set to change December 5, so you don’t have long to maximize your stake.
Don’t miss your chance to maximize your stake in this co-ownership revolution.